EN IT

Reserved

Chevron: 9 Weeks In, but the Decline Hasn't Delivered

·43 min read
EXECUTIVE VIEW

Chevron is at week 9 of a sell signal. The decline holds its direction but lacks conviction: CMF is nearly balanced and a double bottom is forming in the 180 area. The band flags trading as not recommended.

Reserved analysis Subscribe to read →
Reserved

CSX Corporation: trade in its final stretch, 10th-week window approaching

·44 min read
EXECUTIVE VIEW

CSX is in week 9 of a buy trade with a 12.62% gain and a breakeven stop. All 3 statistical targets of our most advanced model have been hit; the roadmap runs through the final window at week 10.

Reserved analysis Subscribe to read →
Reserved

Cisco Systems: profit locked in, signal fading

·44 min read
EXECUTIVE VIEW

Cisco is at week 8 of a buy trade that has already delivered 40% profit. All 3 targets of our most advanced model have been hit, but the management roadmap runs to week 10. The stop is now at breakeven: risk is zeroed out.

Reserved analysis Subscribe to read →
Reserved

AXA SA: sell signal unconfirmed as technical rebound takes hold

·43 min read
EXECUTIVE VIEW

Four weeks into the sell signal on AXA SA, the market replies with a sharp rebound: +3.4% in the latest weekly session, buy volume at 88%. The downside has never confirmed, and the quality band flags trading as not recommended.

Reserved analysis Subscribe to read →
Reserved

CoreWeave: sell signal is in, but the risk is high

·43 min read
EXECUTIVE VIEW

CoreWeave enters its first week under a sell signal. Setup quality is ordinary and the structure is bearish, but the stock remains above the 200-week average: our model flags trading as not recommended.

Reserved analysis Subscribe to read →
Reserved

CrowdStrike: +52% from entry, model eyes the week-8 window

·44 min read
EXECUTIVE VIEW

CrowdStrike is at week 7 of a buy signal with a 52% gain from entry. All 3 model statistical references have been hit ahead of schedule. The next management window falls at week 8.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn